澳洲市场个股详情

CUV Clinuvel Pharmaceuticals Ltd

添加自选
  • 12.650
  • -0.090-0.71%
延时20分钟行情已收盘 12/11 16:00 (悉尼)
6.33亿总市值18.12市盈率(静)

Clinuvel Pharmaceuticals Ltd关键统计数据

财报

主营构成

财务指标

利润表

资产负债表

现金流量表

季报+年报
显示同比 yoy
隐藏空行 yoy
(FY)2024/06/30
(FY)2023/06/30
(FY)2022/06/30
(FY)2021/06/30
(FY)2020/06/30
(FY)2019/06/30
(FY)2018/06/30
(FY)2017/06/30
(FY)2016/06/30
(FY)2015/06/30
营业总收入
12.59%8,817.83万
19.17%7,832.13万
36.99%6,572.23万
47.32%4,797.56万
4.89%3,256.54万
21.82%3,104.78万
52.42%2,548.57万
169.19%1,672.01万
113.33%621.13万
32.34%291.16万
营业收入
12.59%8,817.83万
19.17%7,832.13万
36.99%6,572.23万
47.32%4,797.56万
4.89%3,256.54万
21.82%3,104.78万
52.42%2,548.57万
169.19%1,672.01万
113.33%621.13万
32.34%291.16万
主营业务成本
14.70%1,008.14万
-16.16%878.95万
122.10%1,048.38万
-50.98%472.03万
40.14%962.98万
14.80%687.13万
47.68%598.53万
8.52%405.29万
43.48%373.48万
-20.10%260.29万
毛利
12.32%7,809.69万
25.88%6,953.18万
27.70%5,523.85万
88.59%4,325.53万
-5.13%2,293.56万
23.98%2,417.64万
53.94%1,950.04万
411.49%1,266.72万
702.49%247.65万
129.18%30.86万
营业费用
18.33%3,009.11万
27.73%2,542.93万
32.45%1,990.84万
30.19%1,503.09万
49.94%1,154.51万
4.72%769.98万
23.23%735.28万
-10.42%596.66万
-42.42%666.07万
119.41%1,156.82万
销售和管理费用
10.89%2,502.52万
27.41%2,256.67万
38.81%1,771.16万
575.61%1,276万
25.75%188.87万
42.89%150.19万
-81.54%105.11万
-10.60%569.37万
-43.68%636.91万
123.62%1,130.95万
-销售费用
----
----
----
----
25.75%188.87万
42.89%150.19万
29.54%105.11万
4.33%81.14万
-2.97%77.77万
55.30%80.16万
-管理费用
10.89%2,502.52万
27.41%2,256.67万
38.81%1,771.16万
--1,276万
----
----
----
-12.68%488.23万
-46.79%559.14万
131.38%1,050.8万
折旧摊销及损耗
44.71%114.23万
4.17%78.94万
-12.03%75.78万
101.44%86.14万
99.67%42.76万
380.80%21.42万
-16.17%4.45万
108.17%5.31万
-3.82%2.55万
-29.18%2.65万
-折旧及摊销
44.71%114.23万
4.17%78.94万
-12.03%75.78万
101.44%86.14万
99.67%42.76万
380.80%21.42万
-16.17%4.45万
108.17%5.31万
-3.82%2.55万
-29.18%2.65万
其他营业费用
89.25%392.35万
44.07%207.32万
2.10%143.9万
-84.73%140.94万
54.23%922.88万
-4.37%598.37万
2,747.85%625.71万
-17.42%21.97万
14.61%26.61万
30.78%23.22万
营业利润
8.85%4,800.58万
24.83%4,410.25万
25.18%3,533万
147.79%2,822.44万
-30.87%1,139.05万
35.64%1,647.66万
81.29%1,214.76万
260.14%670.06万
62.84%-418.41万
-77.87%-1,125.96万
营业外利息收入与支出净额
302.53%287.06万
138.96%71.31万
-43.41%-183.03万
-337.64%-127.62万
-1.20%53.7万
105.54%54.35万
0.02%26.45万
26.89%26.44万
-40.19%20.84万
6.72%34.84万
营业外利息收入
87.54%732.49万
779.56%390.59万
29.77%44.41万
-39.21%34.22万
-0.31%56.29万
113.52%56.47万
0.02%26.45万
26.89%26.44万
-40.19%20.84万
6.72%34.84万
营业外利息支出
39.51%445.43万
40.38%319.27万
40.53%227.44万
6,152.14%161.84万
22.60%2.59万
--2.11万
----
----
----
----
其他净收入/费用
-125.87%-19.74万
-7.07%76.31万
166.46%82.12万
-258.14%-123.56万
-11.26%78.13万
81.23%88.05万
405.48%48.58万
-87.93%9.61万
69.38%79.65万
6.78%47.03万
其他营业外收入（费用）
-125.87%-19.74万
-7.07%76.31万
166.46%82.12万
-258.14%-123.56万
-11.26%78.13万
81.23%88.05万
405.48%48.58万
-87.93%9.61万
69.38%79.65万
6.78%47.03万
税前利润
11.19%5,067.9万
32.80%4,557.87万
33.48%3,432.09万
95.73%2,571.26万
-27.48%1,313.65万
39.96%1,811.48万
81.92%1,294.24万
325.58%711.43万
69.72%-315.37万
-88.47%-1,041.44万
所得税
0.46%1,504.26万
11.39%1,497.42万
1,265.55%1,344.25万
128.04%98.44万
-18,057.49%-351.04万
93.14%-1.93万
-28.18万
0
0
0
除税后的权益收益
除税后利润
16.44%3,563.64万
46.58%3,060.46万
-15.57%2,087.85万
48.55%2,472.82万
-8.20%1,664.69万
37.13%1,813.42万
85.88%1,322.42万
325.58%711.43万
69.72%-315.37万
-88.47%-1,041.44万
持续经营利润
16.44%3,563.64万
46.58%3,060.46万
-15.57%2,087.85万
48.55%2,472.82万
-8.20%1,664.69万
37.13%1,813.42万
85.88%1,322.42万
325.58%711.43万
69.72%-315.37万
-88.47%-1,041.44万
归属于少数股东的净利润
-6.65万
归属于母公司的净利润
16.44%3,563.64万
46.58%3,060.46万
-15.57%2,087.85万
48.55%2,472.82万
-8.20%1,664.69万
37.13%1,813.42万
84.16%1,322.42万
327.69%718.08万
69.72%-315.37万
-88.47%-1,041.44万
优先股派息
其他优先股派息
归属于普通股股东的净利润
16.44%3,563.64万
46.58%3,060.46万
-15.57%2,087.85万
48.55%2,472.82万
-8.20%1,664.69万
37.13%1,813.42万
84.16%1,322.42万
327.69%718.08万
69.72%-315.37万
-88.47%-1,041.44万
基本每股收益
15.51%0.715
46.34%0.619
-15.40%0.423
47.93%0.5
-10.11%0.338
35.74%0.376
85.91%0.277
312.86%0.149
70.83%-0.07
-67.83%-0.24
稀释每股收益
18.10%0.698
46.65%0.591
-16.74%0.403
46.67%0.484
-9.84%0.33
37.08%0.366
86.71%0.267
304.29%0.143
70.83%-0.07
-67.83%-0.24
每股派息
25.00%0.05
60.00%0.04
0.00%0.025
0.00%0.025
25.00%0.025
0.02
会计准则
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)2024/06/30(FY)2023/06/30(FY)2022/06/30(FY)2021/06/30(FY)2020/06/30(FY)2019/06/30(FY)2018/06/30(FY)2017/06/30(FY)2016/06/30(FY)2015/06/30
营业总收入 12.59%8,817.83万19.17%7,832.13万36.99%6,572.23万47.32%4,797.56万4.89%3,256.54万21.82%3,104.78万52.42%2,548.57万169.19%1,672.01万113.33%621.13万32.34%291.16万
营业收入 12.59%8,817.83万19.17%7,832.13万36.99%6,572.23万47.32%4,797.56万4.89%3,256.54万21.82%3,104.78万52.42%2,548.57万169.19%1,672.01万113.33%621.13万32.34%291.16万
主营业务成本 14.70%1,008.14万-16.16%878.95万122.10%1,048.38万-50.98%472.03万40.14%962.98万14.80%687.13万47.68%598.53万8.52%405.29万43.48%373.48万-20.10%260.29万
毛利 12.32%7,809.69万25.88%6,953.18万27.70%5,523.85万88.59%4,325.53万-5.13%2,293.56万23.98%2,417.64万53.94%1,950.04万411.49%1,266.72万702.49%247.65万129.18%30.86万
营业费用 18.33%3,009.11万27.73%2,542.93万32.45%1,990.84万30.19%1,503.09万49.94%1,154.51万4.72%769.98万23.23%735.28万-10.42%596.66万-42.42%666.07万119.41%1,156.82万
销售和管理费用 10.89%2,502.52万27.41%2,256.67万38.81%1,771.16万575.61%1,276万25.75%188.87万42.89%150.19万-81.54%105.11万-10.60%569.37万-43.68%636.91万123.62%1,130.95万
-销售费用 ----------------25.75%188.87万42.89%150.19万29.54%105.11万4.33%81.14万-2.97%77.77万55.30%80.16万
-管理费用 10.89%2,502.52万27.41%2,256.67万38.81%1,771.16万--1,276万-------------12.68%488.23万-46.79%559.14万131.38%1,050.8万
折旧摊销及损耗 44.71%114.23万4.17%78.94万-12.03%75.78万101.44%86.14万99.67%42.76万380.80%21.42万-16.17%4.45万108.17%5.31万-3.82%2.55万-29.18%2.65万
-折旧及摊销 44.71%114.23万4.17%78.94万-12.03%75.78万101.44%86.14万99.67%42.76万380.80%21.42万-16.17%4.45万108.17%5.31万-3.82%2.55万-29.18%2.65万
其他营业费用 89.25%392.35万44.07%207.32万2.10%143.9万-84.73%140.94万54.23%922.88万-4.37%598.37万2,747.85%625.71万-17.42%21.97万14.61%26.61万30.78%23.22万
营业利润 8.85%4,800.58万24.83%4,410.25万25.18%3,533万147.79%2,822.44万-30.87%1,139.05万35.64%1,647.66万81.29%1,214.76万260.14%670.06万62.84%-418.41万-77.87%-1,125.96万
营业外利息收入与支出净额 302.53%287.06万138.96%71.31万-43.41%-183.03万-337.64%-127.62万-1.20%53.7万105.54%54.35万0.02%26.45万26.89%26.44万-40.19%20.84万6.72%34.84万
营业外利息收入 87.54%732.49万779.56%390.59万29.77%44.41万-39.21%34.22万-0.31%56.29万113.52%56.47万0.02%26.45万26.89%26.44万-40.19%20.84万6.72%34.84万
营业外利息支出 39.51%445.43万40.38%319.27万40.53%227.44万6,152.14%161.84万22.60%2.59万--2.11万----------------
其他净收入/费用 -125.87%-19.74万-7.07%76.31万166.46%82.12万-258.14%-123.56万-11.26%78.13万81.23%88.05万405.48%48.58万-87.93%9.61万69.38%79.65万6.78%47.03万
其他营业外收入（费用） -125.87%-19.74万-7.07%76.31万166.46%82.12万-258.14%-123.56万-11.26%78.13万81.23%88.05万405.48%48.58万-87.93%9.61万69.38%79.65万6.78%47.03万
税前利润 11.19%5,067.9万32.80%4,557.87万33.48%3,432.09万95.73%2,571.26万-27.48%1,313.65万39.96%1,811.48万81.92%1,294.24万325.58%711.43万69.72%-315.37万-88.47%-1,041.44万
所得税 0.46%1,504.26万11.39%1,497.42万1,265.55%1,344.25万128.04%98.44万-18,057.49%-351.04万93.14%-1.93万-28.18万000
除税后的权益收益
除税后利润 16.44%3,563.64万46.58%3,060.46万-15.57%2,087.85万48.55%2,472.82万-8.20%1,664.69万37.13%1,813.42万85.88%1,322.42万325.58%711.43万69.72%-315.37万-88.47%-1,041.44万
持续经营利润 16.44%3,563.64万46.58%3,060.46万-15.57%2,087.85万48.55%2,472.82万-8.20%1,664.69万37.13%1,813.42万85.88%1,322.42万325.58%711.43万69.72%-315.37万-88.47%-1,041.44万
归属于少数股东的净利润 -6.65万
归属于母公司的净利润 16.44%3,563.64万46.58%3,060.46万-15.57%2,087.85万48.55%2,472.82万-8.20%1,664.69万37.13%1,813.42万84.16%1,322.42万327.69%718.08万69.72%-315.37万-88.47%-1,041.44万
优先股派息
其他优先股派息
归属于普通股股东的净利润 16.44%3,563.64万46.58%3,060.46万-15.57%2,087.85万48.55%2,472.82万-8.20%1,664.69万37.13%1,813.42万84.16%1,322.42万327.69%718.08万69.72%-315.37万-88.47%-1,041.44万
基本每股收益 15.51%0.71546.34%0.619-15.40%0.42347.93%0.5-10.11%0.33835.74%0.37685.91%0.277312.86%0.14970.83%-0.07-67.83%-0.24
稀释每股收益 18.10%0.69846.65%0.591-16.74%0.40346.67%0.484-9.84%0.3337.08%0.36686.71%0.267304.29%0.14370.83%-0.07-67.83%-0.24
每股派息 25.00%0.0560.00%0.040.00%0.0250.00%0.02525.00%0.0250.02
会计准则 US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
热议
澳大利亚
综合热度
股票代码
最新价
涨跌幅

暂无数据

相关主题投资 医疗保健 - 癌症研究
医疗保健 - 癌症研究
今日-0.88%